As of 2025, retatrutide has not received MHRA or EMA marketing authorisation in the UK and remains in Phase 3 clinical trials
Tirzepatide entered the market as a revolutionary treatment that significantly outperformed existing options
In addition, this report is a consensus of expert endocrinologists representing South Asian countries including India, Pakistan, Bangladesh, Nepal, Sri Lanka, Afghanistan and the Maldives on essential recommendations related to the use of GLP-1 RAs in a real-world scenario
Some compounding pharmacies offer semaglutide with glycine and B12 combined, providing the stabilizing and therapeutic benefits of glycine alongside the energy and nutritional support of B12
Weivoda, M
In rare cases, it may lead to more serious effects like gallbladder issues, which is why medical supervision is important